Ganciclovir CAS 82410-32-0 API BW 759 GCV Antiviral CMV Inhibitor High Quality

Tsanangudzo Pfupi

Zita reKemikari: Ganciclovir

CAS: 82410-32-0

Chitarisiko: Ichena kusvika Kure-Ichena Crystalline Powder

Chiyero: 98.0% ~ 102.0%

Antiviral Agent Kurapa kweCytomegalovirus (CMV) Infection

API High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Tsanangudzo:

Mugadziri Wekutengesa ane Kuchena Kwepamusoro uye Hunhu Hwakagadzikana
Zita reKemikari: Ganciclovir
CAS: 82410-32-0
Antiviral Agent yeKurapa kweCytomegalovirus (CMV) Infection
API High Quality, Commercial Production

Chemical Properties:

Chemical Name Ganciclovir
Mashoko anoreva zvakafanana GCV;BW 759;9- [[2-Hydroxy-1-(hydroxymethyl)ethoxy]methyl]guanine;2-Amino-9- (1,3-dihydroxypropan-2-yloxymethyl) -3H-purin-6-imwe;2'-Nor-2'-Deoxyguanosine
Nhamba yeCAS 82410-32-0
Nhamba yeCAT RF-API82
Stock Status MuStock, Kugadzirwa Kunokwira Kusvika Matani
Molecular Formula C9H13N5O4
Molecular Weight 255.23
Melting Point 250 ℃
Storage Temperature 2-8℃
Brand Ruifu Chemical

Zvinotsanangurwa:

Item Zvinotsanangurwa
Chitarisiko Ichena kusvika kuOff-White Crystalline Powder
Solubility Yakanyanya Kunyungudika MuMvura
Identification Ultraviolet Absorption, Infrared Absorption
Kurasika paKuomesa ≤6.0%
Residue paIgnition ≤0.10%
Related Substances Ganciclovir Related Compound A ≤0.50%
Muganhu weGuanine ≤0.50%
Residual Solvents (GC) Ethanol ≤5000ppm
Heavy Metals ≤10ppm
Absorption Coefficient 516-548 pa252nm
Bacterial Endotoxins ≤0.84EU/mg
Assay 98.0%~102.0% (Titration)
Test Standard Enterprise Standard;United States Pharmacopoeia (USP) Standard
Usage API, CMV Inhibitor

Package & Kuchengeta:

Package: Bhodhoro, Aluminium foil bag, Cardboard dhiramu, 25kg/Drum, kana zvinoenderana nezvinodiwa nemutengi.

Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza, mwando uye tumbuyu.

Zvakanakira:

1

FAQ:

Application:

Ganciclovir (CAS 82410-32-0) ndeye nucleoside antiviral mishonga, iri rudzi rweguanosine derivatives.Ganciclovir inonzi parenterally-active antiviral agent inoratidzwa nokuda kwekuona- kana hupenyu hunotyisidzira cytomegalovirus (CMV) zvirwere muvarwere vasina immunocompromised.Iine yakakura-yakasiyana-siyana, yakakwirira-inoshanda inhibitory mhedzisiro paherpes virus uye ndiyo yekutanga-sarudzo mushonga wekurapa cytomegalovirus hutachiona hune simba rakasimba pahutachiona hwehepatitis B uye adenovirus zvakare.Ihomologue yeacyclovir (ACV) ine antiviral mhedzisiro yakafanana, asi yakasimba kupfuura aciclovir, ine zvakanyanya inhibitory mhedzisiro pa cytomegalovirus yakabatana nevarwere veAIDS.Ikiriniki inoshandiswa kurapa induction chikamu uye danho rekugadzirisa pavarwere vasina immunocompromised (kusanganisira varwere veAIDS) vane cytomegalovirus retinitis yakafanana.Inogonawo kushandiswa kudzivirira cytomegalovirus chirwere kune varwere vanogamuchira organ transplantation kana AIDS varwere vane migumisiro yakanaka cytomegalovirus serology bvunzo.

Ganciclovir (CAS 82410-32-0) inoshanda zvakanyanya, yakaderera-chepfu uye yakakwirira-selectivity virus inhibitor yakagadzirwa neSyntex Company (United States).Ndiwo mushonga wekutanga wakabvumidzwa neUS FDA kurapwa kwechirwere checytomegalovirus (CMV).Syntex yakapihwa kodzero yega yekugadzira.Muna Chikumi 1988, piritsi iri rakabvumidzwa kekutanga kunyorwa muUK, richiteverwa nekubvumidzwa zvakatevedzana neFrance, United States, Japan, neWest Germany, Italy neCanada nedzimwe nyika.Kusvika pakupera kwaChikumi 1999, yakabvumidzwa munyika dzinopfuura makumi manomwe uye matunhu ekudzivirira immunodeficiency varwere uye cytomegalovirus utachiona hwevarwere of organ transplantation.Muna 2002, mapiritsi eGanciclovir akawana mvumo kubva kuFDA, ave kuwanikwa izvozvi.

Nyora meseji yako pano uye titumire kwatiri